Karin E Smedby

Karin Ekström Smedby

Professor/assistant senior physician

About me

Karin Ekström Smedby is a professor of haematology-oncology, focusing on clinical epidemiology.

Research description

Selected publications

Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study.
Øvlisen AK, Jakobsen LH, Eloranta S, Kragholm KH, Hutchings M, Frederiksen H, Kamper P, Dahl-Sørensen RB, Stoltenberg D, Weibull CE, Entrop JP, Glimelius I, Smedby KE, Torp-Pedersen C, Severinsen MT, El-Galaly TC
J Clin Oncol 2021 Jun;():JCO2100357

Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study.
Wästerlid T, Hasselblom S, Joelsson J, Weibull CE, Rassidakis G, Sander B, Smedby KE
Blood Cancer J 2021 May;11(5):100

Myocardial infarction in diffuse large B-cell lymphoma patients - a population-based matched cohort study.
Ekberg S, Harrysson S, Jernberg T, Szummer K, Andersson PO, Jerkeman M, Smedby KE, Eloranta S
J Intern Med 2021 May;():

Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival.
Glimelius I, Smedby KE, Albertsson-Lindblad A, Crowther MJ, Eloranta S, Jerkeman M, Weibull CE
Blood Adv 2021 03;5(6):1638-1647

Late toxicities in non-Hodgkin lymphoma: extended follow-up matters.
Thanarajasingam G, Smedby KE, LaCasce A
Lancet Haematol 2021 04;8(4):e242-e243

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden.
Harrysson S, Eloranta S, Ekberg S, Enblad G, Jerkeman M, Wahlin BE, Andersson PO, Smedby KE
Blood Cancer J 2021 Jan;11(1):9

Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study.
Wästerlid T, Oren Gradel K, Eloranta S, Glimelius I, El-Galaly TC, Frederiksen H, Smedby KE
Br J Haematol 2021 02;192(3):551-559

Cancer survival statistics for patients and healthcare professionals - a tutorial of real-world data analysis.
Eloranta S, Smedby KE, Dickman PW, Andersson TM
J Intern Med 2021 01;289(1):12-28

Statin use is associated with improved survival in multiple myeloma: A Swedish population-based study of 4315 patients.
Brånvall E, Ekberg S, Eloranta S, Wästerlid T, Birmann BM, Smedby KE
Am J Hematol 2020 06;95(6):652-661

Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study.
Biccler JL, Glimelius I, Eloranta S, Smeland KB, Brown PN, Jakobsen LH, Frederiksen H, Jerkeman M, Fosså A, Andersson TML, Holte H, Bøgsted M, El-Galaly TC, Smedby KE
J Clin Oncol 2019 03;37(9):703-713

Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up.
Lockmer S, Østenstad B, Hagberg H, Holte H, Johansson AS, Wahlin BE, Wader KF, Steen CB, Meyer P, Maisenhølder M, Smedby KE, Brown P, Kimby E
J Clin Oncol 2018 Oct;():JCO1800262


PhD, Karolinska Institutet

MD, Uppsala University